Gemtuzumab ozogamicin for relapsed or primary refractory acute myeloid leukemia in children—the Polish Pediatric Leukemia and Lymphoma Study Group experience

Overview of attention for article published in Frontiers in immunology, December 2023

Altmetric Badge

Mentioned by

So far, Dimensions has found 1 citation of this research output.

The most recent citing publication is shown below. View this citation on Dimensions.

Article in Molecular Cancer (March 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.